Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

Delayed Quote. Delayed Nasdaq - 10/20 10:00:00 pm
44.78 USD   -0.44%
10/19 DEXCOM : Announces Upcoming Conference Presentation
10/10 DEXCOM SCHEDULE : 30 p.m. Eastern Time
09/28 DexCom and Rite Aid tumble while Abbott and AbbVie rise
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
44.97(c) 44.99(c) 44.95(c) 44.98(c) 44.78(c) Last
2 195 878 1 527 495 1 322 915 1 326 838 912 189 Volume
-2.32% +0.04% -0.09% +0.07% -0.44% Change
More quotes
Financials ($)
Sales 2017 718 M
EBIT 2017 -59,4 M
Net income 2017 -57,6 M
Finance 2017 282 M
Yield 2017 -
Sales 2018 885 M
EBIT 2018 -16,2 M
Net income 2018 -30,9 M
Finance 2018 315 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 5,03x
EV / Sales2018 4,04x
Capitalization 3 894 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
10/19 DEXCOM : Announces Upcoming Conference Presentation
10/19 DEXCOM : Sensor, Glucose, G4/G5
10/19 DEXCOM : 65-- DEXCOM, Sensor, Glucose, G4/G5
10/10 DEXCOM SCHEDULES THIRD QUARTER 2017 : 30 p.m. Eastern Time
10/03 Alphatec Accelerates Business Transformation with Additional Spine-Experience..
09/28 DexCom and Rite Aid tumble while Abbott and AbbVie rise
09/28 DEXCOM : Opens Data Platform and Launches Developer Program to Fuel Diabetes App..
09/19 DEXCOM : Opens Data Platform and Launches Developer Program to Fuel Diabetes App..
09/19 DEXCOM : International Trade Commission Receives Complaint From Dexcom
09/14 FITBIT : and Dexcom to Develop Continuous Glucose Monitoring CGM Experience for ..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/11 Mondi drags on FTSE, Provident Financial sinks
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
10/20Zacks Investment Research Lowers DexCom, Inc. $DXCM to Sell  
10/19DexCom Announces Upcoming Conference Presentation: SAN DIEGO--(BUSINESS WIRE).. 
10/19DexCom : Announces Upcoming Conference Presentation  
10/19$DXCM DexCom Announces Upcoming Conference Presentation From our Stock News A.. 
10/18Insulet and Dexcom Partner to Offer Choices for Animas Users: BILLERICA, Mass.. 
More tweets
Qtime:99
News from SeekingAlpha
10/05 Top 10 Market Negatives - Cramer's Mad Money (10/4/17)
09/29 BIOTECH FORUM DAILY DIGEST : Momentum Building For Heron Therapeutics?
09/29 Abbott, Alere, and Approvals, Oh My
09/28 Midday Gainers / Losers
09/28 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 72,0 $
Spread / Average Target 60%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Quentin Blackford Chief Financial Officer
Jacob Leach Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.-24.71%3 891
MEDTRONIC PLC10.18%106 457
BAXTER INTERNATIONAL43.98%34 785
ZIMMER BIOMET HOLDINGS INC16.95%24 403
C R BARD INC45.55%23 764
HOYA CORPORATION29.06%21 882